| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |